Guard Therapeutics
Sweden - StockholmBiotechnology
Focus: Guard Therapeutics is a Swedish public biotech focused on A1M protein-targeting therapeutics across oncology, nephrology, and rare diseases. The company operates at public-stage with a diversified pipeline spanning early-to-late clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Guard Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Guard Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Crisis Intervention - The First Line Leaders
Crisis Response PlanClinical Trials (1)
NCT07032636Reducing Crises and Suicide Within the Idaho Army National Guard
N/AHelp build intelligence for Guard Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.